Glucagon‐like peptide agonists: A prospective review
Abstract Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) have emerged as promising therapeutic options for addressing Type‐2 diabetes, obesity, and related conditions. Among these, semaglutide, tirzepatide, liraglutide etc., all notable GLP‐1RA, have gained attention owing to their f...
| الحاوية / القاعدة: | Endocrinology, Diabetes & Metabolism |
|---|---|
| المؤلفون الرئيسيون: | , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Wiley
2024-01-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1002/edm2.462 |